<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Jerry Fahrni &#187; ISMP</title>
	<atom:link href="http://jerryfahrni.com/tag/ismp/feed/" rel="self" type="application/rss+xml" />
	<link>http://jerryfahrni.com</link>
	<description>Pharmacy Informatics and Technology</description>
	<lastBuildDate>Sun, 05 Feb 2012 04:39:21 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Don&#8217;t confuse Durezol and Durasal (S.A.L.A.D.)</title>
		<link>http://jerryfahrni.com/2012/01/dont-confuse-durezol-and-durasal-s-a-l-a-d/</link>
		<comments>http://jerryfahrni.com/2012/01/dont-confuse-durezol-and-durasal-s-a-l-a-d/#comments</comments>
		<pubDate>Tue, 03 Jan 2012 21:04:29 +0000</pubDate>
		<dc:creator>Jerry Fahrni</dc:creator>
				<category><![CDATA[Medication Safety]]></category>
		<category><![CDATA[fda]]></category>
		<category><![CDATA[ISMP]]></category>
		<category><![CDATA[Medication Errors]]></category>
		<category><![CDATA[Patient Safety]]></category>

		<guid isPermaLink="false">http://jerryfahrni.com/?p=6198</guid>
		<description><![CDATA[PharmQD: “FDA is alerting pharmacists and other health care professionals of potential injury due to confusion between the FDA-approved eye medicine Durezol (difluprednate ophthalmic emulsion) 0.05% and the unapproved prescription topical wart remover Durasal (salicylic acid) 26%. There has been one report of serious injury when a pharmacist mistakenly gave an eye surgery patient Durasal, <a href='http://jerryfahrni.com/2012/01/dont-confuse-durezol-and-durasal-s-a-l-a-d/'>[...]</a>]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.pharmqd.com/pharmacy-news/fda-alerts-pharmacists-and-health-care-professionals-potential-injury-when-dispensing-"><font size="3">PharmQD</font></a><font size="3">: “<em>FDA is alerting pharmacists and other health care professionals of potential injury due to confusion between the FDA-approved eye medicine Durezol (difluprednate ophthalmic emulsion) 0.05% and the unapproved prescription topical wart remover Durasal (salicylic acid) 26%.</em></font></p>
<p><font size="3"><em>There has been one report of serious injury when a pharmacist mistakenly gave an eye surgery patient Durasal, the salicylic acid–containing wart remover, instead of the prescribed Durezol eye drops. Durezol is approved for treatment of inflammation and pain association with ocular surgery.”</em></font></p>
<p><font size="3"><font size="3">Seems like I’ve read about this mistake </font><a href="http://www.ismp.org/newsletters/acutecare/showarticle.asp?id=5"><font size="3">before</font></a>. Being their typical efficient self, the <a href="http://www.fda.gov/Drugs/DrugSafety/ucm285235.htm">FDA alert</a> was issued on December 28, 2011, more than three months after ISMP alerted everyone. </font></p>
<p><font size="3">Some things you can do to prevent stuff like this from happening include (taken from a <a href="http://pharmacytimes.com/publications/issue/2011/December2011/High-Alert-Medications-Involved-in-Wrong--Drug-Errors">Pharmacy Times article</a>):</font></p>
<ul>
<li><font size="3">Include both brand and generic names, along with indication, when prescribing look- or sound-alike drug names.</font> </li>
<li><font size="3">Spell out drug names that have been confused when accepting telephone orders. Require staff to write down the prescription and then perform a read back (and spell back for drugs that are known to cause confusion) of the complete prescription for verification.</font> </li>
<li><font size="3">Assign time to provide counseling to patients and/or caregivers, especially for new prescriptions.</font> </li>
</ul>
<p><font size="3">&#160;</font></p>
]]></content:encoded>
			<wfw:commentRss>http://jerryfahrni.com/2012/01/dont-confuse-durezol-and-durasal-s-a-l-a-d/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ISMP launches first self assessment of ADC safety</title>
		<link>http://jerryfahrni.com/2009/06/ismp-launches-first-self-assessment-of-adc-safety/</link>
		<comments>http://jerryfahrni.com/2009/06/ismp-launches-first-self-assessment-of-adc-safety/#comments</comments>
		<pubDate>Thu, 18 Jun 2009 16:17:42 +0000</pubDate>
		<dc:creator>Jerry Fahrni</dc:creator>
				<category><![CDATA[Automation]]></category>
		<category><![CDATA[ADC]]></category>
		<category><![CDATA[ISMP]]></category>

		<guid isPermaLink="false">http://jerryfahrni.com/?p=765</guid>
		<description><![CDATA[ISMP.org: &#8220;More than 80% of US hospitals have implemented automated dispensing cabinets (ADCs) as an important part of their drug distribution system, making the evaluation of practices surrounding this technology an essential step in ensuring patient safety. To help meet healthcare organizations’ growing need for assistance in this area, ISMP has introduced the first Medication <a href='http://jerryfahrni.com/2009/06/ismp-launches-first-self-assessment-of-adc-safety/'>[...]</a>]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.ismp.org/">ISMP.org</a>: &#8220;<em>More than 80% of US hospitals have implemented automated dispensing cabinets (ADCs) as an important part of their drug distribution system, making the evaluation of practices surrounding this technology an essential step in ensuring patient safety. To help meet healthcare organizations’ growing need for assistance in this area, ISMP has introduced the first </em><a href="http://www.ismp.org/selfassessments/ADC/survey.pdf"><em>Medication Safety Self Assessment for Automated Dispensing Cabinets</em></a><em>. The assessment contains 12 core elements that support the safe use of ADCs, which are based on guidelines developed by a national forum convened by ISMP comprising practitioners and vendors with expertise in the safe use of ADCs.** Many of the core elements represent system improvements and safeguards that ISMP has recommended in response to analysis of medication errors and problems identified during onsite ISMP consultations with hospitals</em>. &#8221; &#8211; ISMP offers some great resources and their self assessments are are a good way to see exactly where you stand against their &#8220;standards&#8221;. I would encourage every acute care facility using ADCs to complete the survey and submit their data to ISMP, confidentially of course.</p>
]]></content:encoded>
			<wfw:commentRss>http://jerryfahrni.com/2009/06/ismp-launches-first-self-assessment-of-adc-safety/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Problems with barcodes.</title>
		<link>http://jerryfahrni.com/2009/05/problems-with-barcodes/</link>
		<comments>http://jerryfahrni.com/2009/05/problems-with-barcodes/#comments</comments>
		<pubDate>Thu, 21 May 2009 21:22:48 +0000</pubDate>
		<dc:creator>Jerry Fahrni</dc:creator>
				<category><![CDATA[Barcoding]]></category>
		<category><![CDATA[ISMP]]></category>

		<guid isPermaLink="false">http://jerryfahrni.com/?p=502</guid>
		<description><![CDATA[ISMP Medication Safety Alert! May 21, 2009 Vol. 14, Issue 10: &#8220;Please let us know if you identify problems with  a company’s unit dose package barcode. An example of an ARICEPT (donepezil) unit-dose package with a barcode  problem appears in Figure 1 (shown in the PDF version of the newsletter). Note that the labeling material has been applied to the <a href='http://jerryfahrni.com/2009/05/problems-with-barcodes/'>[...]</a>]]></description>
			<content:encoded><![CDATA[<p><a href="http://ismp.org/Newsletters/acutecare/currentissue.asp">ISMP Medication Safety Alert! May 21, 2009 Vol. 14, Issue 10</a>: <em><strong>&#8220;Please let us know if you identify problems </strong><a href="http://jerryfahrni.com/wp-content/uploads/2009/05/bar_barcode.gif"><img class="alignleft size-full wp-image-503" title="bar_barcode" src="http://jerryfahrni.com/wp-content/uploads/2009/05/bar_barcode.gif" alt="bar_barcode" width="223" height="199" /></a><strong>with  a</strong><span style="font-style: normal;"><em><strong> company’s unit dose package barcode. An example of an </strong></em><em><strong>ARICEPT</strong></em><em><strong> (donepezil) unit-dose package with a barcode  problem appears in Figure 1 (shown in the PDF version of the newsletter). Note that the labeling material has been applied to the unit-dose package in such a way that tearing the doses apart destroys the barcode! Problems like this are due to inadequate quality control and are by no means isolated to one company. When issues like this occur, staff are forced to take extra steps to maintain the quality of the barcode, or they have to relabel products so they can be scanned at the bedside. This, of course, takes time and also increases the risk of a labeling error. If you send barcode problems to us along with a publishable photo, it will help us remind companies about the need for adequate quality control.&#8221;  <span style="font-style: normal;">- <span style="font-weight: normal;">Fortunately for us we haven&#8217;t seen anything like this, yet.</span></span></strong></em></span></em></p>
<p><em><span style="font-style: normal;"><em><span style="color: #0000ee; text-decoration: underline;"><br />
</span></em></span></em></p>
]]></content:encoded>
			<wfw:commentRss>http://jerryfahrni.com/2009/05/problems-with-barcodes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

